Cancer Genetics & Molecular Oncology
Clinician referral requiredBRCA1 and BRCA2 Mutations (Tumour)
Looks for BRCA1 and BRCA2 mutations in tumour tissue.
- Method: Next Generation Sequencing (NGS)
- Sample: Tissue block
- Turnaround: 21 days
Guidance
Our team can help clinicians and patients identify the appropriate test.
For clinicians
Request forms, sample handling and scientific support.
Collection
Give your sample at one of 17 centres across Sri Lanka.
Search our testing catalogue by test name, condition, gene or clinical area. Each test page includes guidance for patients and ordering information for clinicians.
42 testsin Cancer Genetics & Molecular Oncology
Cancer Genetics & Molecular Oncology
Clinician referral requiredLooks for BRCA1 and BRCA2 mutations in tumour tissue.
Cancer Genetics & Molecular Oncology
Clinician referral requiredLooks for ABL1 mutations linked to resistance to tyrosine kinase inhibitor treatment in BCR-ABL positive leukaemia.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects ALK gene rearrangements in a tumour tissue block.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects four translocations seen in acute lymphoblastic leukaemia: t(9;22), t(12;21), t(4;11) and t(1;19).
Cancer Genetics & Molecular Oncology
Clinician referral requiredCombines the AML and ALL translocation panels on one sample.
Cancer Genetics & Molecular Oncology
Clinician referral requiredTests for t(15;17), t(8;21), inv(16), NPM1, FLT3-ITD, FLT3-TKD, IDH1, IDH2 and TP53 in acute myeloid leukaemia.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects three rearrangements seen in acute myeloid leukaemia: t(15;17), t(8;21) and inv(16).
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects the BCR-ABL fusion and identifies the p190, p210 or p230 type.
Cancer Genetics & Molecular Oncology
Clinician referral requiredMeasures BCR-ABL transcript levels on the International Scale (IS) to monitor treatment response.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects the BRAF V600E mutation in tumour tissue, bone marrow or blood.
Cancer Genetics & Molecular Oncology
Clinician referral requiredTests six genes from a blood sample: BRCA1, BRCA2, BARD1, TP53, PTEN and PALB2.
Cancer Genetics & Molecular Oncology
Clinician referral requiredLooks for large insertions and deletions in BRCA1 and BRCA2 that sequencing can miss.
Cancer Genetics & Molecular Oncology
Clinician referral requiredTests mutation hotspots across 50 cancer-related genes.
Cancer Genetics & Molecular Oncology
Clinician referral requiredTests five DPYD variants linked to the risk of severe side effects from fluoropyrimidine chemotherapy.
Cancer Genetics & Molecular Oncology
Clinician referral requiredLooks for EGFR mutations in tumour tissue by Sanger sequencing. Lower sensitivity than NGS.
Cancer Genetics & Molecular Oncology
Clinician referral requiredTests EGFR exons 18 to 21 together with KRAS, BRAF and MET in tumour tissue.
Cancer Genetics & Molecular Oncology
Clinician referral requiredLooks for FGFR3 mutations in bladder cancer tissue.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects the FIP1L1-PDGFRA fusion gene in bone marrow or blood.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects FLT3 internal tandem duplications (ITD) in bone marrow or blood.
Cancer Genetics & Molecular Oncology
Clinician referral requiredTests KIT, PDGFRA and BRAF in gastrointestinal stromal tumour (GIST) tissue.
Cancer Genetics & Molecular Oncology
Clinician referral requiredChecks a tumour tissue block for HER2 gene amplification.
Cancer Genetics & Molecular Oncology
Clinician referral requiredTests homologous recombination repair (HRR) genes in tumour tissue.
Cancer Genetics & Molecular Oncology
Clinician referral requiredLooks for IDH1 and IDH2 mutations in glioma tissue.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetermines the mutation status of the immunoglobulin heavy chain variable (IGHV) region.
Cancer Genetics & Molecular Oncology
Clinician referral requiredLooks for mutations in exon 12 of the JAK2 gene.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects the JAK2 V617F mutation in a blood sample.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects the KIT D816V mutation in bone marrow or blood.
Cancer Genetics & Molecular Oncology
Clinician referral requiredCombines EGFR, ALK, ROS1 and PD-L1 testing on lung cancer tissue.
Cancer Genetics & Molecular Oncology
Clinician referral requiredFISH panel for myelodysplastic syndromes (MDS).
Cancer Genetics & Molecular Oncology
Clinician referral requiredTests JAK2 V617F, JAK2 exon 12, MPL and CALR in myeloproliferative neoplasms.
Cancer Genetics & Molecular Oncology
Clinician referral requiredChecks tumour tissue for microsatellite instability.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects the MYD88 L265P mutation in a blood sample.
Cancer Genetics & Molecular Oncology
Clinician referral requiredLooks for NPM1 mutations in bone marrow or blood.
Cancer Genetics & Molecular Oncology
Clinician referral requiredMeasures PD-L1 protein expression in tumour tissue using the SP263 antibody.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects the PML-RARA fusion in bone marrow or blood.
Cancer Genetics & Molecular Oncology
Clinician referral requiredLooks for mutations in the POLE gene (DNA polymerase epsilon, catalytic subunit) in tumour tissue.
Cancer Genetics & Molecular Oncology
Clinician referral requiredTests KRAS, NRAS, BRAF and PIK3CA in colon cancer tissue.
Cancer Genetics & Molecular Oncology
Clinician referral requiredDetects ROS1 gene rearrangements in a tumour tissue block.
Cancer Genetics & Molecular Oncology
Clinician referral requiredTests BRAF, KRAS, NRAS, HRAS and RET in thyroid tumour tissue.
Cancer Genetics & Molecular Oncology
Clinician referral requiredLooks for TP53 mutations in bone marrow or blood.
Cancer Genetics & Molecular Oncology
Clinician referral requiredChecks tumour tissue for loss of chromosome arms 1p and 19q.
Cancer Genetics & Molecular Oncology
Clinician referral requiredSequences the protein-coding regions of tumour DNA to profile acquired mutations.